Clinical trials
Hypertension trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Unknown status | 13 |
| Recruiting | 11 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 2 |
| No longer available | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Changi General Hospital | 5 |
| Novartis Pharmaceuticals | 5 |
| Singapore General Hospital | 5 |
| Duke-NUS Graduate Medical School | 4 |
| National Heart Centre Singapore | 4 |
| Novartis | 4 |
| Alexandra Hospital | 2 |
| Jens Titze | 2 |
| National University Hospital, Singapore | 2 |
| National University of Singapore | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 55 |
| Cardiovascular Diseases | 11 |
| Diabetes Mellitus, Type 2 | 8 |
| Diabetes Mellitus | 5 |
| Renal Insufficiency, Chronic | 5 |
| Hyperaldosteronism | 4 |
| Hyperlipidemias | 4 |
| Obesity | 4 |
| Stroke | 4 |
| Dyslipidemias | 3 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.